Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.46 |
| ▸ | SPHK1 | Q9NYA1 | 7/20 | 0.45 |
| ▸ | SPHK2 | Q9NRA0 | 6/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | FASN | P49327 | 1/20 | 0.39 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11687578 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11688324 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8727383 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855730 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL5685367 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11689950 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855829 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL11809342 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855705 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 | |
| SCHEMBL8855707 | 1.00 | ALDH1A1 (0.50) | ALDH1A1TSHRTHRBEPHX1SPHK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0612835-A2 | Refrigerating machine oil composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-08-31 | — | — | EP | claimed |
| WO-2023235556-A2 | EPOXIDE COMPOUNDS, METHODS OF PREPARATIONS AND USES THEREOF | ZSCHIMMER & SCHWARZ, INC. (US) | 2023-12-07 | — | — | WO | disclosed |
| US-11795153-B1 | Epoxide compounds, methods of preparations and uses thereof | ZSCHIMMER & SCHWARZ, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| US-11795153-B1 | Epoxide compounds, methods of preparations and uses thereof | ZSCHIMMER & SCHWARZ, INC. (US) | 2023-10-24 | — | — | US | disclosed |
| EP-2470628-B1 | MULTI-GRADE ENGINE OIL FORMULATIONS COMPRISING AN ESTER COMPONENT | CHEVRON USA INC (US) | 2017-08-30 | — | — | EP | disclosed |
| EP-2250241-B1 | SYNTHESIS OF DIESTER-BASED BIOLUBRICANTS FROM EPOXIDES | CHEVRON USA INC (US) | 2016-12-21 | — | — | EP | disclosed |
| US-9109238-B2 | Synthesis of diester-based lubricants from enzymatically-directed epoxides | CHEVRON U.S.A. INC. (US) | 2015-08-18 | — | — | US | disclosed |
| US-20150140623-A1 | Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides | NOVOZYMES A/S (DK) | 2015-05-21 | — | — | US | disclosed |
| US-8795547-B2 | Refrigeration oil from gas-to-liquid-derived and bio-derived triesters | CHEVRON U.S.A. INC. (US) | 2014-08-05 | — | — | US | disclosed |
| US-8585919-B2 | Refrigeration oil from gas-to-liquid derived and bio-derived diesters | CHEVRON U.S.A. INC. (US) | 2013-11-19 | — | — | US | disclosed |
| US-6348608-B1 | ADDING OXIDIZING AGENT TO REACTION SOLUTION COMPRISING CHIRAL CYCLIC ENANTIOMERICALLY ENRICHED KETONE AND OLEFIN UNDER CONDITIONS EFFECTIVE TO GENERATE ENANTIOMERICALLY ENRICHED EPOXIDE, SEPARATING EPOXIDE FROM REACTION SOLUTION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2002-02-19 | — | — | US | disclosed |
| EP-1021426-A4 | CATALYTIC ASYMMETRIC EPOXIDATION | UNIV COLORADO STATE RES FOUND (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-1021426-A1 | CATALYTIC ASYMMETRIC EPOXIDATION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2000-07-26 | — | — | EP | disclosed |
| EP-0979220-A1 | SINGLE-STAGE METHOD FOR PRODUCING ALPHA-HYDROXY ETHERS BY OXIDIZING C=C-UNSATURATED COMPOUNDS WITH HYDROPEROXIDES | SASOL Germany GmbH (DE) | 2000-02-16 | — | — | EP | disclosed |
| WO-1998047844-A1 | SINGLE-STAGE METHOD FOR PRODUCING α-HYDROXY ETHERS BY OXIDIZING C=C-UNSATURATED COMPOUNDS WITH HYDROPEROXIDES | RWE-DEA Aktiengesellschaft für Mineraloel und Chemie (DE) | 1998-10-29 | — | — | WO | disclosed |
| WO-1998015544-A1 | CATALYTIC ASYMMETRIC EPOXIDATION | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 1998-04-16 | — | — | WO | disclosed |
| US-5454963-A | Refrigerating machine oil composition containing an epoxy compound | IDEMITSU KOSAN CO., LTD. (JP) | 1995-10-03 | — | — | US | disclosed |
| EP-0612835-A2 | Refrigerating machine oil composition | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1994-08-31 | — | — | EP | disclosed |
| US-4013723-A | REACTION OF AN OXIRANE WITH HYDROGEN PEROXIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-22 | — | — | US | disclosed |
| US-3974224-A | HYDROGEN PEROXIDE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11795153-B1 | Epoxide compounds, methods of preparations and uses thereof | EPHX2, EPHX1, VKORC1 | ALDH1A1 315/4885TSHR 4765/4885THRB 4660/4885 |
| US-20150140623-A1 | Synthesis of Diester-Based Lubricants from Enzymatically-Directed Epoxides | DGAT2, ADH1A, ELOVL1 | ALDH1A1 39/4885TSHR 3247/4885THRB 2739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.